Bank of America’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-376,892
| Closed | -$9.01M | – | 8420 |
|
|
2021
Q1 | $9.01M | Sell |
376,892
-725,734
| -66% | -$13.5M | ﹤0.01% | 2827 |
|
|
2020
Q4 | $16.1M | Buy |
1,102,626
+25,747
| +2% | +$341K | ﹤0.01% | 2089 |
|
|
2020
Q3 | $15.3M | Buy |
1,076,879
+55,888
| +5% | +$854K | ﹤0.01% | 1928 |
|
|
2020
Q2 | $15M | Sell |
1,020,991
-1,768,478
| -63% | -$18M | ﹤0.01% | 1851 |
|
|
2020
Q1 | $11.5M | Buy |
2,789,469
+693,250
| +33% | +$3.25M | ﹤0.01% | 1952 |
|
|
2019
Q4 | $10.1M | Buy |
2,096,219
+425,891
| +25% | +$2.35M | ﹤0.01% | 2547 |
|
|
2019
Q3 | $10.1M | Buy |
1,670,328
+156,533
| +10% | +$977K | ﹤0.01% | 2499 |
|
|
2019
Q2 | $9.82M | Buy |
1,513,795
+152,248
| +11% | +$1.07M | ﹤0.01% | 2578 |
|
|
2019
Q1 | $9.65M | Buy |
1,361,547
+158,037
| +13% | +$1.04M | ﹤0.01% | 2507 |
|
|
2018
Q4 | $5.85M | Buy |
1,203,510
+210,171
| +21% | +$1.09M | ﹤0.01% | 2840 |
|
|
2018
Q3 | $7.3M | Buy |
993,339
+83,908
| +9% | +$616K | ﹤0.01% | 2823 |
|
|
2018
Q2 | $5.8M | Sell |
909,431
-4,194
| -0.5% | -$27.7K | ﹤0.01% | 3008 |
|
|
2018
Q1 | $4.97M | Buy |
913,625
+49,417
| +6% | +$246K | ﹤0.01% | 3089 |
|
|
2017
Q4 | $3.6M | Buy |
864,208
+565,756
| +190% | +$3.4M | ﹤0.01% | 3420 |
|
|
2017
Q3 | $2.87M | Buy |
298,452
+297,206
| +23,853% | +$3.09M | ﹤0.01% | 3682 |
|
|
2017
Q2 | $14K | Sell |
1,246
-6,468
| -84% | -$82.7K | ﹤0.01% | 6342 |
|
|
2017
Q1 | $99K | Sell |
7,714
-26,071
| -77% | -$314K | ﹤0.01% | 5634 |
|
|
2016
Q4 | $414K | Buy |
33,785
+31,767
| +1,574% | +$377K | ﹤0.01% | 4939 |
|
|
2016
Q3 | $23K | Sell |
2,018
-2,412
| -54% | -$23.3K | ﹤0.01% | 6084 |
|
|
2016
Q2 | $38K | Sell |
4,430
-243,420
| -98% | -$1.67M | ﹤0.01% | 5957 |
|
|
2016
Q1 | $1.31M | Sell |
247,850
-1,020
| -0.4% | -$5.68K | ﹤0.01% | 3907 |
|
|
2015
Q4 | $1.93M | Sell |
248,870
-489,299
| -66% | -$3.76M | ﹤0.01% | 3827 |
|
|
2015
Q3 | $5.81M | Sell |
738,169
-71,003
| -9% | -$657K | ﹤0.01% | 2743 |
|
|
2015
Q2 | $7.33M | Buy |
809,172
+7,409
| +0.9% | +$74.7K | ﹤0.01% | 2222 |
|
|
2015
Q1 | $10.4M | Buy |
801,763
+185
| +0% | +$2.42K | ﹤0.01% | 1835 |
|
|
2014
Q4 | $10.9M | Sell |
801,578
-60,326
| -7% | -$674K | ﹤0.01% | 1856 |
|
|
2014
Q3 | $7.73M | Sell |
861,904
-88,980
| -9% | -$957K | ﹤0.01% | 2161 |
|
|
2014
Q2 | $12.9M | Buy |
950,884
+420
| +0% | +$4.38K | ﹤0.01% | 1727 |
|
|
2014
Q1 | $9.45M | Buy |
950,464
+163,358
| +21% | +$2.03M | ﹤0.01% | 1824 |
|
|
2013
Q4 | $10.5M | Sell |
787,106
-518
| -0.1% | -$6.29K | ﹤0.01% | 1823 |
|
|
2013
Q3 | $9.56M | Sell |
787,624
-53,244
| -6% | -$571K | ﹤0.01% | 1837 |
|
|
2013
Q2 | $8.7M | Buy |
+840,868
| New | +$11.6M | ﹤0.01% | 1832 |
|
Bank of America's GNMK Position: Q2 2021 in Review
Bank of America sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 376,892 shares — an estimated $9.01M sold.
Bank of America first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $16.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Bank of America reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Bank of America sold 376,892 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $9.01M.
- Bank of America first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- Bank of America's GenMark Diagnostics, Inc position peaked at $16.1M in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.